Quantcast

Posts related to ‘MBRX’

Top Analyst Downgrades (ACN, FCX, MBRX, NXY, PFG, RBA)

Posted: March 31, 2009 at 7:12 am

These are some of the top analyst downgrades or cautious research calls we have seen this Tuesday morning before the market opens: Accenture (ACN) Cut to Hold at Argus. Freeport-McMoRan ...
Read Full Story »

Metabasis Escapes Biotech Zombiedom (MBRX)

Posted: October 2, 2007 at 5:34 pm

Metabasis Therapeutics (NASDAQ:MBRX) announced after the close today that its MB07133 has been granted orphan medicinal product status for the treatment of hepatocellular carcinoma (primary liver cancer) by the European ...
Read Full Story »

Metabasis Therapeutics (MBRX): Another Biopharma Microcap Implodes

Posted: July 17, 2007 at 8:40 am

Metabasis Therapeutics (MBRX) is off 56% to $3 after its diabetes drug candidate CS-917 failed to significantly lower blood sugar in a mid-stage trial. The company has traded as high ...
Read Full Story »